Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors

Front Oncol. 2019 Sep 20:9:902. doi: 10.3389/fonc.2019.00902. eCollection 2019.

Claudio Vernieri^{1

2}, Sara Pusceddu¹, Filippo de Braud^{1

3}

¹ Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
³ Oncology and Hematology-Oncology Department, University of Milan, Milan, Italy.

No abstract available

Keywords: diabetes mellitus; glucose; lipid metabolism; metabolism; metformin; pancreatic neuroendocrine tumors.